An Acute Immune Response to Middle East Respiratory Syndrome Coronavirus Replication Contributes to Viral Pathogenicity
- PMID: 26724387
- PMCID: PMC4816712
- DOI: 10.1016/j.ajpath.2015.10.025
An Acute Immune Response to Middle East Respiratory Syndrome Coronavirus Replication Contributes to Viral Pathogenicity
Abstract
Middle East respiratory syndrome coronavirus (MERS-CoV) was first identified in a human with severe pneumonia in 2012. Since then, infections have been detected in >1500 individuals, with disease severity ranging from asymptomatic to severe, fatal pneumonia. To elucidate the pathogenesis of this virus and investigate mechanisms underlying disease severity variation in the absence of autopsy data, a rhesus macaque and common marmoset model of MERS-CoV disease were analyzed. Rhesus macaques developed mild disease, and common marmosets exhibited moderate to severe, potentially lethal, disease. Both nonhuman primate species exhibited respiratory clinical signs after inoculation, which were more severe and of longer duration in the marmosets, and developed bronchointerstitial pneumonia. In marmosets, the pneumonia was more extensive, with development of severe airway lesions. Quantitative analysis showed significantly higher levels of pulmonary neutrophil infiltration and higher amounts of pulmonary viral antigen in marmosets. Pulmonary expression of the MERS-CoV receptor, dipeptidyl peptidase 4, was similar in marmosets and macaques. These results suggest that increased virus replication and the local immune response to MERS-CoV infection likely play a role in pulmonary pathology severity. Together, the rhesus macaque and common marmoset models of MERS-CoV span the wide range of disease severity reported in MERS-CoV-infected humans, which will aid in investigating MERS-CoV disease pathogenesis.
Copyright © 2016 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Comparative pathology of rhesus macaque and common marmoset animal models with Middle East respiratory syndrome coronavirus.PLoS One. 2017 Feb 24;12(2):e0172093. doi: 10.1371/journal.pone.0172093. eCollection 2017. PLoS One. 2017. PMID: 28234937 Free PMC article.
-
A Comparative Review of Animal Models of Middle East Respiratory Syndrome Coronavirus Infection.Vet Pathol. 2016 May;53(3):521-31. doi: 10.1177/0300985815620845. Epub 2016 Feb 11. Vet Pathol. 2016. PMID: 26869154 Review.
-
Pathogenicity and Viral Shedding of MERS-CoV in Immunocompromised Rhesus Macaques.Front Immunol. 2018 Feb 12;9:205. doi: 10.3389/fimmu.2018.00205. eCollection 2018. Front Immunol. 2018. PMID: 29483914 Free PMC article.
-
Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease.J Virol. 2015 Apr;89(7):3659-70. doi: 10.1128/JVI.03427-14. Epub 2015 Jan 14. J Virol. 2015. PMID: 25589660 Free PMC article.
-
Animal models of Middle East respiratory syndrome coronavirus infection.Antiviral Res. 2015 Oct;122:28-38. doi: 10.1016/j.antiviral.2015.07.005. Epub 2015 Jul 17. Antiviral Res. 2015. PMID: 26192750 Free PMC article. Review.
Cited by
-
Emerging respiratory infections: The infectious disease pathology of SARS, MERS, pandemic influenza, and Legionella.Semin Diagn Pathol. 2019 May;36(3):152-159. doi: 10.1053/j.semdp.2019.04.006. Epub 2019 Apr 17. Semin Diagn Pathol. 2019. PMID: 31054790 Free PMC article. Review.
-
Prophylactic and therapeutic efficacy of mAb treatment against MERS-CoV in common marmosets.Antiviral Res. 2018 Aug;156:64-71. doi: 10.1016/j.antiviral.2018.06.006. Epub 2018 Jun 7. Antiviral Res. 2018. PMID: 29885377 Free PMC article.
-
Imaging Features of Coronavirus disease 2019 (COVID-19): Evaluation on Thin-Section CT.Acad Radiol. 2020 May;27(5):609-613. doi: 10.1016/j.acra.2020.03.002. Epub 2020 Mar 20. Acad Radiol. 2020. PMID: 32204990 Free PMC article.
-
IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes.J Clin Invest. 2019 Jul 29;129(9):3625-3639. doi: 10.1172/JCI126363. eCollection 2019 Jul 29. J Clin Invest. 2019. PMID: 31355779 Free PMC article.
-
Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents.Virol J. 2020 Oct 15;17(1):154. doi: 10.1186/s12985-020-01415-w. Virol J. 2020. PMID: 33059711 Free PMC article. Review.
References
-
- Zaki A.M., van Boheemen S., Bestebroer T.M., Osterhaus A.D., Fouchier R.A. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367:1814–1820. - PubMed
-
- Reusken C.B., Farag E.A., Jonges M., Godeke G.J., El-Sayed A.M., Pas S.D., Raj V.S., Mohran K.A., Moussa H.A., Ghobashy H., Alhajri F., Ibrahim A.K., Bosch B.J., Pasha S.K., Al-Romaihi H.E., Al-Thani M., Al-Marri S.A., AlHajri M.M., Haagmans B.L., Koopmans M.P. Middle East respiratory syndrome coronavirus (MERS-CoV) RNA and neutralising antibodies in milk collected according to local customs from dromedary camels, Qatar, April 2014. Euro Surveill. 2014;19:8–12. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources